Updates & Ideas

Inspecs - Margins enhanced by moving Eschenbach acetate manufacture to Vietnam

January 2024

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

Last January, Inspecs (SPEC; 81p) experienced a significant surge, soaring from my 42p NAP price to 140p (a 233% increase). Most of this movement occurred in a single day when it reported results, and investors perceived that all the negative news was factored into the price. However, high inflation saw institutional investors facing redemptions and become forced sellers bringing the shares back and causing much bawling and tearing out of hair for directors. Investec forecasts eps of 10.2p for the just-ended year, with 11.8p this year and 13.6p next making it a good time for a second bite at the cherry. Established in 1988, Inspecs specializes in designing and manufacturing frames for corrective eyewear and sunglasses. In the init ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

ADVT

Growth Portfolio 3 - January '24

Inspecs - Q1 signals the corner is turned (May 2024)

Inspecs (February 2024)

Inspecs (October 2023)

Inspecs (August 2023)

Inspecs - EBITDA forecast to jump US$6m this year (July 2023)

Inspecs (May 2023)

Inspecs (February 2023)

Inspecs - Interesting new issue (March 2020)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X